Daniel Anderson

Assistant Professor

Daniel Anderson

Assistant Professor

Academic Appointment(s)

Medical College of Georgia
Department of Pharmacology and Toxicology

Medical College of Georgia
Department of Medicine

  • DANDERSON3@augusta.edu
  • (706) 721-1915
  • CB 3630

Education

  • PHARMD, Pharmacy (PharmD [USA] PharmD, University of Georgia, 2018

Certifications

  • Board Certified Infectious Diseases Pharmacist Board of Pharmacy Specialties , 2020

  • Georgia Pharmacist License State of GA, 2018

  • PHM State of GA, 2018

Awards & Honors

  • Exemplary Teaching Award MCG, 2025

  • Preceptor of the Year University of Georgia College of Pharmacy, 2022

Courses Taught Most Recent Academic Year

  • MEDI 6320

    Brain, Behavior, & Movement
  • BIOM 8120

    Cardiovas Physio & Pharma
  • PHRM 8042

    Pharmacology & Therapeutics I
  • PHRM 9020

    Seminar in Pharmacology

Teaching Interests

​Infectious Diseases, Antimicrobial Stewardship, Antimicrobial Resistance, Pharmacokinetics

Scholarship

Selected Recent Publications

  • Evaluation of Adjunctive Aminoglycoside Therapy Compared to β-Lactam Monotherapy in Critically Ill Patients with Gram-Negative Bloodstream Infections, 2025
    Journal Article, Academic Journal
  • Histoplasma capsulatum Prosthetic Valve Endocarditis Diagnosed via Cell-Free DNA Sequencing., 2025
    Journal Article, Academic Journal
  • Evaluation of short versus long courses of antibiotics in critically ill patients with Gram-negative bloodstream infections, 2024
    Journal Article, Academic Journal
  • Guidelines for the Prevention, Diagnosis, and Management of Urinary Tract Infections in Pediatrics and Adults: A WikiGuidelines Group Consensus Statement, 2024
    Journal Article, Academic Journal
  • Evaluation of Sequential Oral Versus Intravenous Antibiotic Treatment of Enterococcus faecalis Bloodstream Infections, 2024
    Journal Article, Academic Journal

Research Interests

Managing infections caused by multidrug resistant organisms, optimizing antimicrobial stewardship practices, and managing antimicrobial therapy in immunocompromised patients.